Priveterra Acquisition Corporation II News - PMGM

Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Priveterra Acquisition Corp. II (NASDAQ: PMGMU, PMGM, PMGMW) (the “Company”) today announced that on April 29, 2024, the Company received a...

Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. (Nasdaq: PMGM) (“Priveterra”), a special purpose acquisition company led by Chairman & CEO, Robert Palmisano...

Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. (Nasdaq: PMGM) (“Priveterra” and, after the consummation of its pending business combination (the “Business...

Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. (Nasdaq: PMGM) (“Priveterra” and, after the consummation of its pending business combination (the “Business...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Priveterra Acquisition Corporation II (PMGM)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

PMGM News

Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Amended Statement of Ownership (sc 13g/a)

PMGM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Priveterra Acquisition Corporation II (PMGM) News

Priveterra Acquisition Corporation II (PMGM)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

PMGM News

Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Amended Statement of Ownership (sc 13g/a)

PMGM Discussion

Your Recent History